Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Am J Obstet Gynecol. 2022 Feb 22;227(1):61.e1–61.e18. doi: 10.1016/j.ajog.2022.02.022

Table 7:

Comparison by body mass index

RRSO Control
Pre-RRSO Post-RRSO Baseline Follow-up P1 P2 P3
BMI BMI BMI BMI
18.5–<25kg/m2 25–<30kg/m2 30–<35kg/m2 ≥35kg/m2 18.5–<25kg/m2 25–<30kg/m2 30–<35kg/m2 ≥35kg/m2 18.5–<25kg/m2 25–<30kg/m2 30–<35kg/m2 ≥35kg/m2 18.5–<25kg/m2 25–<30kg/m2 30–<35kg/m2 ≥35kg/m2
N 64 65 27 23 64 65 27 23 18 10 6 4 18 10 6 4
Testosterone 0.22 (0.15, 0.29) 0.2 (0.17, 0.23) 0.2 (0.16, 0.24) 0.2 (0.15, 0.25) 0.15 (0.12, 0.18) 0.17 (0.13, 0.22) 0.16 (0.09, 0.23) 0.16 (0.09, 0.24) 0.21 (0.15, 0.27) 0.16 (0.12, 0.21) 0.14 (0.08, 0.2) 0.21 (0.1, 0.33) 0.19 (0.15, 0.22) 0.15 (0.12, 0.18) 0.12 (0.06, 0.17) 0.21 (0.08, 0.36) 0.78 <0.01 0.02
Androstenedione 0.58 (0.51, 0.66) 0.52 (0.45, 0.59) 0.49 (0.38, 0.61) 0.48 (0.38, 0.58) 0.49 (0.42, 0.56) 0.46 (0.41, 0.52) 0.45 (0.36, 0.54) 0.45 (0.36, 0.55) 0.54 (0.43, 0.66) 0.49 (0.32, 0.69) 0.42 (0.32, 0.53) 0.38 (0.31, 0.45) 0.51 (0.37, 0.65) 0.43 (0.34, 0.53) 0.36 (0.3, 0.43) 0.38 (0.15, 0.64) 0.77 <0.01 0.85
Androstenediol 241.3 (213.3, 272.8) 248.6 (210.1, 294.2) 234.1 (177.5, 308.6) 264.1 (213.3, 326.8) 224.9 (191.2, 264.5) 231.8 (190.2, 282.4) 227.1 (167.7, 307.5) 216 (173.0, 269.6) 253.7 (189.4, 339.7) 216.0 (157.2, 296.7) 195.4 (116.7, 326.7) 274.9 (164.7, 458.3) 218.2 (165.9, 286.9) 191.5 (130.9, 279.9) 180.3 (100.9, 321.5) 236.5 (129.6, 430.7) 0.54 <0.01 0.71
Dihydrotestosterone 36.7 (32.0, 42.0) 32.1 (27.2, 37.9) 27.8 (21.9, 35.2) 26.1 (20.1, 33.8) 31.8 (27.2, 37.1) 29.9 (24.4, 36.5) 23.8 (17.6, 32.0) 20.1 (15.7, 25.7) 41.5 (28.9, 59.4) 28.7 (20.2, 40.5) 21.6 (11.3, 40.6) 32.1 (23.7, 43.4) 38.3 (27.5, 53.0) 26.7 (19.3, 36.7) 19.1 (9.4, 37.7) 28.1 (16.6, 46.9) 0.14 0.05 0.69
Androsterone 115.7 (103.0, 130.0) 112.3 (97.2, 129.8) 104.6 (81.7, 134.0) 113.4 (95.0, 135.4) 98.5 (85.9, 112.8) 111.2 (95.5, 129.4) 116.9 (91.3, 149.7) 101.5 (77.6, 132.7) 125.5 (97.5, 161.3) 92.7 (66.0, 129.9) 102.5 (63.6, 165.0) 125.5 (99.9, 157.4) 105.7 (79.5, 140.4) 113.4 (80.4, 159.9) 87.2 (55.4, 137.1) 112.3 (71.9, 175.1) 0.75 0.06 0.39
Dehydroepiandrosterone 2.1 (1.8, 2.4) 2.1 (1.8, 2.4) 1.8 (1.4, 2.3) 1.9 (1.5, 2.3) 2.0 (1.7, 2.3) 2.0 (1.7, 2.4) 2.0 (1.5, 2.7) 1.8 (1.4, 2.3) 2.2 (1.6, 2.9) 1.8 (1.2, 2.6) 1.9 (1.2, 2.8) 1.7 (1.1, 2.5) 1.8 (1.4, 2.3) 1.5 (1.0, 2.2) 1.5 (0.8, 2.6) 1.9 (1.2, 2.8) 0.98 <0.01 0.70
Estrone 16.3 (13.7, 19.4) 18.7 (15.2, 22.9) 23.8 (17.8, 31.6) 28.4 (22.2, 36.2) 14.0 (11.7, 16.8) 18.1 (14.5, 22.5) 16.8 (13.6, 20.8) 24.0 (19.0, 30.3) 20.1 (14.7, 27.4) 15.6 10.3, 23.4) 22.6 (17.0, 29.9) 26.1 (15.3, 44.1) 19.3 (13.5, 27.3) 19.1 (12.7, 28.5) 18.5 (10.4, 32.3) 23.3 (11.4, 46.8) 0.76 <0.01 0.32
Estradiol 3.8 (2.7, 5.2) 5.4 (3.8, 7.5) 6.2 (3.8, 9.9) 8.1 (6.0, 10.8) 2.4 (1.9, 3.0) 3.9 (3.0, 4.9) 3.7 (2.9, 4.8) 6.0 (4.6, 7.7) 5.7 (3.1, 10.0) 4.0 (2.6, 5.9) 5.2 (3.9, 6.7) 7.6 (3.5, 15.4) 4.2 (1.9, 8.0) 4.1 (2.5, 6.2) 4.1 (2.5, 6.4) 6.4 (3.3, 11.8) 0.22 <0.01 0.02
SHBG 96.5 (85.5, 109) 62.4 (53.8, 72.4) 48.4 (37.2, 62.8) 35.6 (26.4, 47.9) 98.5 (86.6, 112) 64.4 (55.2, 75.0) 44.6 (35.8, 55.5) 36.7 (27.1, 49.6) 103.6 (79.4, 135) 60.6 (42.8, 85.6) 54.1 (34.2, 85.3) 65.7 (25.8, 165) 102.5 (80.8, 130.1) 59.9 (45.1, 79.6) 58.1 (39.9, 84.5) 63.7 (40.6, 99.6) <0.01 0.80 0.14

P1: Body mass index; P2: Pre vs. Post; P3: RSSO vs. Controls